CD160 and diffuse large B-cell lymphoma: Consistent with our bioinformatics results, TIM3 (p < 0.001; Figure 5(a)), PD-L1 (p < 0.05; Figure 5(b)), LAG3 (p < 0.05; Figure 5(c)), CD160 (p < 0.05; Figure 5(d)), and CD244 (p < 0.05; Figure 5(e)) displayed significantly higher mRNA expression levels in DLBCL than healthy specimens.